Role of low-density lipoprotein apheresis

American Journal of Cardiology

Volumn 96, Issue 4 SUPPL., 2005, Pages 67-69

  Ziajka, Paul ^a  

^a Florida Lipid Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SIMVASTATIN;

ANGIOGRAPHY; APHERESIS; ATHEROSCLEROSIS; BLOOD FLOW; CARDIOVASCULAR EFFECT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; ECHOGRAPHY; ENDOTHELIUM; HEART MUSCLE PERFUSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPOTENSION; LIFESTYLE; OUTCOMES RESEARCH; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 23744457577     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.06.012     Document Type: Conference Paper

References (18)

1. National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP-III) Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP-III) 2002 National Institutes of Health Bethesda, MD VI-1 VI-4 NIH Publication No. 02-5215.
2. A. Vella, A. Pineda, T. O'Brien Low density lipoprotein apheresis for the treatment of refractory hyperlipidemia Mayo Clin Proc 76 2001 1039 1046
3. B. Gordon, E. Stein, P. Jones, D.R. Illingworth Indications for LDL apheresis Am J Cardiol 74 1994 1109 1112
4. D. Lane, P. Alaupovic, C. Knight-Gibson, V. Dudley, L. Laughlin Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal LDL precipitation treatments Am J Cardiol 75 1995 1124 1129
5. D. Seidel H.E.L.P apheresis therapy in the treatment of severe hypercholesterolemia 10 years of clinical experience Artif Organs 20 1996 303 310
6. P. Schuff-Werner, H. Gohlke, U. Bartmann, G. Baggio, M. Corti, A. Dinsenbacher, T. Eiseahaver, P. Grontzmacher, C. Kelker, U. Kettner The H.E.L.P. LDL apheresis multinational study, an angiographically assessed trial on the role of LDL apheresis in the secondary prevention of coronary heart disease Eur J Clin Invest 24 1994 724 732
7. A. Kroon, W. van Asten, A. Stalenhoef Effect of apheresis of LDL in peripheral vascular disease in hypercholesterolemic patients with coronary artery disease Ann Intern Med 125 1996 945 954
8. S. Nishimura, M. Sekiguchi, T. Kano, S. Ishiwata, F. Nagasaki, T. Nishiae, T. Okimoto, Y. Kutsumi, Y. Kuwabara, F. Takatsu Effects of intensive lipid lowering by LDL apheresis on regression of coronary atherosclerosis in patients with familial hyperlipidemia Japan Low density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS) Atherosclerosis 144 1999 409 417
9. M. Matsuzaki, K. Hiramori, T. Imaizumi, A. Kitabatake, H. Hishida, N. Nomura, T. Fuji, I. Sakuma, K. Fukami, T. Honda Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein apheresis in familial hyperlipidemia J Am Coll Cardiol 40 2002 220 227
10. D. Waters, L. Higginson, P. Gladstone, B. Kimball, M. Le May, S. Boccuzzi, J. Lesperance Effect of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative angiography the Canadian Coronary Atherosclerosis Intervention Trial Circulation 89 1994 959 968
11. S.E. Nissun, E.M. Tuzcu, P. Schoenhagen, B.G. Brown, P. Ganz, R.A. Vogel, T. Crowe, G. Howard, C.J. Cooper, B. Brodie Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) investigators Effects of intensive compared with moderate lipid lowering therapy on the progression of coronary atherosclerosis JAMA 291 2004 1071 1080
12. K. Mellwig, D. Baller, U. Gleichmann, D. Moll, S. Betker, R.R. Weiss, G. Notohamiprodjo Improvement of coronary vasodilation capacity through a single LDL apheresis Atherosclerosis 139 1998 173 178
13. T. Sampietro, F. Bigazzi, B. DalPino, S. Fusaro, G. Sassi, C.C. Marchetti, G. Sambuccti, M. Tuomi, O. Pandi, A. Bionda Improvement of myocardial blood flows by single LDL apheresis assessed with PET 2000 Presented at the International Symposium on Atherosclerosis; June 25-29; Stockholm, Sweden. Abstract WeP35:W26.
14. O. Tamai, H. Matsuka, H. Itabe, Y. Wada, K. Kohno, T. Imaizumi Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans Circulation 95 1997 76 82
15. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of coronary heart disease events and death with pravastatin in patients with coronary heart disease and a range of initial cholesterol levels N Engl J Med 339 1998 1349 1357
16. Scandinavian Simvastatin Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study Lancet 344 1994 1383 1389
17. H. Mabuchi, J. Koizumi, M. Shimizu, K. Kajinami, K. Miyamoto, K. Ueda, T. Takegoshi Long term efficacy of low density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia Am J Cardiol 82 1998 1489 1495
18. B. Gordon, S. Kelsey, P. Dau, A. Gotto, Y. Graham, R. Illingworth, J. Isaacson, P. Jones, S. Letman, S. Saal Long term effects of LDL apheresis using automated dextran sulfate cellulose adsorption system Am J Cardiol 81 1998 407 411